Serum IgA levels induced by rotavirus natural infection, but not following immunization with the RRV-TV vaccine (Rotashield™), correlate with protection

被引:15
作者
González, R
Franco, M
Sarmiento, L
Romero, M
Schael, IP
机构
[1] Cent Univ Venezuela, Inst Biomed Fuvesin, Secc Invest Enfermedades Entericas Infancia, Minist Salud & Desarrollo Social, Caracas 1010A, Venezuela
[2] Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia
[3] Cent Univ Venezuela, Inst Inmunol, Postgrado Inmunol Clin, Minist Salud & Desarrollo Social, Caracas 1010A, Venezuela
[4] Ciudad Hosp Dr Enrique Tejera CHET, Valencia, Estado Carabobo, Venezuela
基金
英国医学研究理事会;
关键词
diarrhea; immune response;
D O I
10.1002/jmv.20404
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To directly compare serum rotavirus specific IgA as a marker of protection in children vaccinated with the RRV-TV (Rotashield (TM)) vaccine and in naturally infected children, we studied preexisting rotavirus IgA antibodies by ELISA assays in these groups of children within the first 5 days after the onset of a diarrhea episode, due or not to rotavirus. In immunized children, rotavirus IgA titers were similar between infected and non-RV infected children. In non-immunized children, the proportion with rotavirus IgA titers was significantly greater in non-RV infected children (58%) than in infected children (31%). Additionally, a titer >= 1:800 was associated with 68% protection. Thus, in this study serum rotavirus IgA showed a good correlation with protection in children pre-exposed to natural infection but not in those immunized with the RRV-TV vaccine. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:608 / 612
页数:5
相关论文
共 26 条
  • [1] ROTAVIRUS FECAL IGA ANTIBODY-RESPONSE IN ADULTS CHALLENGED WITH HUMAN ROTAVIRUS
    BERNSTEIN, DI
    ZIEGLER, JM
    WARD, RL
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1986, 20 (04) : 297 - 304
  • [2] Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial
    Bernstein, DI
    Sack, DA
    Rothstein, E
    Reisinger, K
    Smith, VE
    O'Sullivan, D
    Spriggs, DR
    Ward, RL
    [J]. LANCET, 1999, 354 (9175) : 287 - 290
  • [3] Circulating rotavirus-specific antibody-secreting cells (ASCs) predict the presence of rotavirus-specific ASCs in the human small intestinal lamina propria
    Brown, KA
    Kriss, JA
    Moser, CA
    Wenner, WJ
    Offit, PA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) : 1039 - 1043
  • [4] ROLE OF COPROANTIBODY IN CLINICAL-PROTECTION OF CHILDREN DURING REINFECTION WITH ROTAVIRUS
    COULSON, BS
    GRIMWOOD, K
    HUDSON, IL
    BARNES, GL
    BISHOP, RF
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) : 1678 - 1684
  • [5] FENG N, 1995, J VIROL, V68, P7766
  • [6] FENG NG, 1995, J VIROL, V69, P3246
  • [7] Challenges for rotavirus vaccines
    Franco, MA
    Greenberg, HB
    [J]. VIROLOGY, 2001, 281 (02) : 153 - 155
  • [8] INTESTINAL AND SERUM IMMUNE-RESPONSE TO A NATURALLY ACQUIRED ROTAVIRUS GASTROENTERITIS IN CHILDREN
    HJELT, K
    GRAUBALLE, PC
    SCHIOTZ, PO
    ANDERSEN, L
    KRASILNIKOFF, PA
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1985, 4 (01) : 60 - 66
  • [9] PROTECTIVE EFFECT OF PREEXISTING ROTAVIRUS-SPECIFIC IMMUNOGLOBULIN-A AGAINST NATURALLY ACQUIRED ROTAVIRUS INFECTION IN CHILDREN
    HJELT, K
    GRAUBALLE, PC
    PAERREGAARD, A
    NIELSEN, OH
    KRASILNIKOFF, PA
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (01) : 39 - 47
  • [10] The role of serum antibodies in the protection against rotavirus disease: An overview
    Jiang, BM
    Gentsch, JR
    Glass, RI
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (10) : 1351 - 1361